ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,205,857 | +66.3% | 13,511 | +99.8% | 0.06% | +107.1% |
| Q1 2023 | $725,022 | +27.2% | 6,762 | +44.9% | 0.03% | +33.3% |
| Q4 2022 | $569,981 | +127.1% | 4,667 | +91.7% | 0.02% | +133.3% |
| Q3 2022 | $251,000 | +20.7% | 2,435 | +8.7% | 0.01% | +50.0% |
| Q2 2022 | $208,000 | -88.3% | 2,241 | -83.0% | 0.01% | -91.3% |
| Q4 2021 | $1,771,000 | -25.9% | 13,165 | -29.0% | 0.07% | -6.8% |
| Q1 2021 | $2,390,000 | – | 18,547 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |